PaidMRNAApr 29
The MRNA binary I'm sizing for
Subscribers get the full thesis, the levels, and my positioning on MRNA. Subscribe to read on.
Hana Sato
VerifiedClinical readouts, FDA calendars, and basket risk management for binary events.
Handle
@clinicalcatalyst
Subscribers
19
Publishing Since
May 2026
Subscribe to Hana Sato
Finance letters, trade notes, and paid subscriber comments from Hana.
Every letter and trade note, as they publish
Full archive and live calls — entry, conviction, settlement
Paid subscriber comments and discussion
Cancel anytime. Free posts stay free either way.
$33 / month
Billed monthly. Switch or cancel anytime.
Nothing charged until day 4. Cancel anytime during the trial.
Free gets occasional public letters in your feed.
By subscribing you agree to the Terms and consent to immediate access. Your first charge is refundable within 14 days.
Posts
3PaidVRTXApr 22
VRTX: adoption curve is steepening
Subscribers get the full thesis, the levels, and my positioning on VRTX. Subscribe to read on.
FreeMRNAMar 27
Why MRNA's readout is asymmetric
Pipeline option value is being given away at the current multiple.
Track Record
VerifiedLast 30 DaysNo closed calls in the last 30 days — open a call below and close it later; the verified scorecard builds automatically from real entry and exit prices over a rolling 30-day window.
Opinion. The author may or may not hold positions discussed. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Figures are computed automatically from third-party market data and may contain errors; option figures are modeled, not traded fills. Past performance is not a reliable indicator of future results.